Furthermore, we observed that CCR5-deficient mice exhibited slower tumor growth than wild-type mice when a syngeneic mouse CRC cell line was injected either subcutaneously or orthotopically into the cecal wall [10]. This evidence concerns the gene CCR5 and neoplasm.